UV-protective single-use bags address a specific vulnerability in biopharmaceutical manufacturing, where UV exposure during production, storage, and cold chain logistics can compromise sensitive products.

Explore safety measures for handling mAbs in production in order to meet strict requirements that prevent contamination, product loss and exposure to cytotoxic agents or radioisotopes.

Dual sourcing strengthens the pharmaceutical supply chain for single-use assemblies. Learn how this strategy and multi-sourcing can enhance resilience and adaptability in the face of disruptions.

With the implementation of a shell solution for their single-use bags, this CDMO managed to reduce its costs for cold chain logistics with single-use bags by more than 60%.

Discover how closed-system approaches in HPAPI and ADC manufacturing reduce operator exposure, support Annex 1 alignment, and deliver labor savings of up to 90%.

ADC payloads active at nanogram concentrations create serious operator safety risks. Here is what manufacturers must get right to protect operators across every stage of production.

Manual bottle filling can introduce significant risks, impacting accuracy, sterility, and compliance. Learn how automation can improve product quality, enhance patient safety, and increase efficiency.

Tired of manual manipulation risks in biopharmaceuticals? Discover how automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.

Learn how the transition to plate-based freezing with single-use technologies improves scalability and contamination control while ensuring uniform thermal transfer for high-value bulk drug substances.

Practical strategies for reducing handling steps, minimizing product loss risk, and improving operator efficiency in frozen drug substance cold chain operations.

Legacy facilities weren't built for today's cold chain complexity. How are CDMOs squeezing more capacity from fixed footprints without breaking what already works?

Uneven ice formation during bottle freezing creates a "Volcano Effect," pushing solutes into highly concentrated zones. This test-based study explains this risk to drug substance quality.

Learn five critical considerations for freezing bottles, including uniform rate control, container integrity, and selecting the right freezing technology to maintain product stability and process efficiency.

Explore the challenges of adding cryoprotectants, how they can help reduce the effects of harmful conditions like ice crystals, and the need for future stability studies and substitutes for toxic CPAs.